A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF NIPOCALIMAB FOR THE TREATMENT OF ADULT PARTICIPANTS WITH MODERATE TO SEVERE BULLOUS PEMPHIGOID

Registry ID

80202135BPG2001

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

JANSSEN INC

Last update

2023-02-23

Conditions

• BULLOUS PEMPHIGOID

View on source registry